Antimicrobial photodynamic therapy (aPDT) may be useful as a supportive antimicrobial measure for caries-active subjects. In this study, the antimicrobial efficacy of aPDT with a phenalen-1-one photosensitizer was evaluated in a novel in vitro biofilm model comprising Actinomyces naeslundii, Actinomyces odontolyticus, and Streptococcus mutans and was compared to chlorhexidine. The proposed biofilm model allows high-throughput screening for antimicrobial efficacy while exhibiting a differentiated response to different antimicrobial approaches. While chlorhexidine 0.2% showed a reduction of ≈4 log 10 for all species, aPDT led to a more pronounced reduction of S. mutans (2.8 log 10 ) than of Actinomyces spp. (1.2 or 1.3 log 10 ). A similar effect was also observed in monospecies biofilms. Therefore, aPDT may be more effective against S. mutans than against Actinomyces spp. when in biofilms, and this antimicrobial approach merits further investigations.
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In this regard, supportive antimicrobial measures may be useful in daily oral hygiene practice additionally to mechanical removal of biofilms for caries-active patient subgroups [ten Cate, 2009] . The widely used antiseptic of choice is chlorhexidine (CHX), either applied as oral rinse or as gel or varnish [Walsh et al., 2015] . However, its actual impact on caries prevention is debated controversially, and its use exhibits some undesirable side effects like yellow-brown staining of teeth and tongue and altering the sense of taste [Autio-Gold, 2008] . Furthermore, recently, its use has been recommended to be limited to "those applications with a clear patient benefit" (mostly in intensive care) for reducing the risk of inducing acquired resistances to CHX or even cross-resistances to antibiotics in pathogens [Kampf, 2016] . Accordingly, Kitagawa et al. [2016] reported that repeated exposure of Enterococcus faecalis to CHX resulted in drug resistance, as demonstrated by increased minimum inhibitory concentrations.
In this instance, antimicrobial photodynamic therapy (aPDT) may be a promising alternative [Gursoy et al., 2013; Wainwright et al., 2017] . aPDT is a 3-component system, consisting of a per se nontoxic dye (photosensitizer [PS] ), light of an appropriate wavelength, and molecular oxygen. When the PS molecule is activated by light, it is transmitted to an excited state, from which there are 2 mechanisms to regain its ground state: in type I mechanism, the charge is transferred to a substrate or molecular oxygen resulting in emergence of oxygen radicals, such as superoxide ions and hydroxyl radicals or hydrogen peroxide. In type II mechanism, energy is transferred to molecular oxygen, resulting in the generation of singlet oxygen ( 1 O 2 ), which is regarded as the most effective reactive oxygen species [Wainwright, 1998; Wainwright et al., 2017] . Hereby, the singlet oxygen quantum yield Φ Δ describes the proportion of type II mechanism [Maisch et al., 2007] . Due to its unselective mechanism of action, the potential of resistance towards aPDT is very unlikely [Giuliani et al., 2010; Tavares et al., 2010] , especially for type II mechanism [Cieplik et al., 2013] . Accordingly, PS based on a phenalen-1-one structure seem to be particularly advantageous due to their high singlet oxygen quantum yield Φ Δ ≥ 0.95 [Cieplik et al., 2013; Späth et al., 2014; Tabenski et al., 2016] . Furthermore, for oral application, esthetic compromises for patients will not be an issue due to the tooth-like color of phenalen-1-one derivatives [Späth et al., 2014] .
However, before any clinical application, it is mandatory to evaluate novel antimicrobial approaches for their efficacy against biofilms, as it is well known that bacteria embedded in biofilms exhibit strongly enhanced tolerance for antimicrobial challenges as compared to their planktonic counterparts [Marsh, 2004] . Accordingly, it is of vital importance to develop in vitro biofilm models that are easy to operate and allow high-throughput screening of given antimicrobial compounds or approaches.
The aim of the present study was to evaluate the antimicrobial efficacy of phenalen-1-one-mediated aPDT on a novel polymicrobial biofilm model cultured from caries-associated bacteria in vitro in comparison to the goldstandard antiseptic CHX.
Materials and Methods

Chemicals and Light Source
The PS used in this study was 2-((4-pyridinyl)methyl)-1H-phenalen-1-one chloride and had been synthetized at the Department of Organic Chemistry (University of Regensburg, Germany), as described earlier in detail (purity ≥99%) [Cieplik et al., 2013; Späth et al., 2014] . PS suspensions were freshly prepared for the experiments and stored in the dark at 4 ° C for no longer than 2 weeks. For irradiation of the PS, a gas discharge lamp (Waldmann PIB 3000; Waldmann Medizintechnik, Villingen-Schwenningen, Germany) was employed (λ em 380-600 nm). Irradiance was adjusted to 50 mW/cm 2 at sample level, resulting in an energy dose of 30 J/ cm 2 for an irradiation period of 10 min. CHX digluconate dissolved in distilled water was prepared by the pharmacy department of the University Medical Center Regensburg yielding concentrations of 0.2 and 2%. [Gmür and Guggenheim, 1983; Guggenheim et al., 2001] . For preparation of planktonic cultures, colonies were picked and suspended in 5 mL of mFUM with 0.5 mL fetal bovine serum (FBS; Gibco ® Life Technologies, Carlsbad, CA, USA) for 24 h under anaerobic conditions to obtain bacteria in the stationary growth phase. Afterwards, suspensions were harvested by centrifugation (ROTINA 420 R, Hettich Lab Technology, Tuttlingen, Germany) and resuspended in mFUM yielding an optical density of 1.0, as measured by means of a spectrophotometer (Ultrospec 3300 pro, Amersham Biosciences, Amersham, UK). Bacterial suspensions were diluted 1: 9 in the biofilm culture medium (BCM) consisting of 50% mFUM, 10% Polyspecies biofilms were formed in 96-well polystyrene culture plates (Corning ® Costar ® , Corning, NY, USA). For simulation of pellicle coating, wells were incubated with saliva for 2 h at room temperature. After that, saliva was discarded, and wells were filled with 200 μL of BCM containing A. naeslundii and A. odontolyticus and incubated under anaerobic conditions. After 16 h, medium was carefully removed and 200 μL fresh BCM containing S. mutans was added. After 48 h, a further medium change was performed, and biofilms were incubated for another 24 h.
Bacterial Culture and Biofilm Formation
Formation of monospecies biofilms was performed accordingly: after a 2-h incubation with saliva, wells were filled with 200 μL of BCM containing A. naeslundii, A. odontolyticus, or S. mutans, respectively. Medium changes were after 24 and 48 h. In all cases, the total culture period was 72 h.
Antimicrobial Assay
After 72 h, medium was carefully discarded from the wells and the biofilms were either incubated with phosphate-buffered saline (PBS; Biochrom, Berlin, Germany; groups PS-L-, PS-L+) or PS (groups PS+ L-, PS+ L+), respectively, in the dark for 10 min and then illuminated for another 10 min or incubated with CHX 0.2% or CHX 2% for a total of 20 min (50 μL each). Immediately afterwards, PBS, PS, or CHX was carefully removed, and each biofilm was brought to suspension with 200 μL of PBS and transferred to an Eppendorf tube. These were placed in an ultrasonic water bath chamber (Sonorex Super RK 102 H, Bandelin, Berlin, Germany) obtaining a frequency of 35 kHz for 10 min and then vortexed (REAX top, Heidolph Instruments, Schwabach, Germany) for 5 s to separate aggregated bacteria. Ten-fold serial dilutions (10 -2 to 10 -7 ) were prepared in PBS, and aliquots (180 μL) were plated on Columbia blood agar and incubated anaerobically for 72 h. Afterwards, colony-forming units (CFU) were evaluated. For polyspecies biofilms, bacteria on agar plates were differentiated by their respective colony morphology.
Data Analysis
All results are shown as medians and neighboring quartiles (25/75% percentiles) and were calculated using SPSS for Windows, version 23 (SPSS Inc., Chicago, IL, USA), from the values of at least 6 independent experiments, each performed in duplicate. Horizontal dotted and dashed lines represent reductions of 3 and 5 log 10 steps of CFU, respectively, compared to the matching untreated control group PS-L-. Medians on or below these lines demonstrate antimicrobial efficacy of at least 99.9% (3 log 10 ) or 99.999% (5 log 10 ), respectively, which is declared as biologically relevant antimicrobial activity or disinfectant effect according to the guidelines of infection control [Boyce and Pittet, 2002] .
Results
Antimicrobial Efficacy against Polyspecies Biofilms
Untreated polyspecies biofilms (PS-L-) showed a slight overgrowth of S. mutans (4.7 × 10 7 ) of ≈1 log 10 step as compared to A. naeslundii (3.8 × 10 6 ) and A. odonto- lyticus (4.3 × 10 6 ). The left panel of Figure 1 shows absolute CFU values of untreated controls, while the right panel depicts relative CFU data with untreated controls (groups PS-L-) set to 100%. aPDT reduced CFU of S. mutans (2.8 log 10 ) more than CFU of A. naeslundii and A. odontolyticus (1.2 or 1.3 log 10 , respectively), while treatment with PS (PS+ L-) or light alone (PS-L+) had no effect. CHX 0.2% reduced CFU of all species by ≈4 log 10 steps (S. mutans: 4.0 log 10 ; A. naeslundii: 4.5 log 10 ; A. odontolyticus: 3.8 log 10 ), while CHX 2% led to eradication by > 6 log 10 below the detection limit.
Antimicrobial Efficacy against Monospecies Biofilms
Untreated monospecies biofilms (groups PS-L-) showed growth of 2 × 10 8 , 4 × 10 7 , and 1 × 10 6 CFU for S. mutans, A. naeslundii, and A. odontolyticus, respectively. Figure 2 shows relative CFU data with untreated controls (groups PS-L-) set to 100%.
CFU reductions for aPDT (PS+ L+) were 3.0 log 10 for S. mutans, while A. naeslundii and A. odontolyticus were reduced by 2.5 log 10 or 1.1 log 10 only. In contrast, CHX 0.2% led to reduction rates of 4.3 log 10 for S. mutans and A. odontolyticus, while CFU of A. naeslundii were reduced by 6.0 log 10 . Treatment with PS (PS+ L-) or light only (PS-L+) had no effect in any cases.
Discussion
The aim of the present study was to investigate the antimicrobial efficacy of phenalen-1-one-mediated aPDT as compared to the gold-standard antiseptic CHX for inactivation of biofilms from cariogenic bacteria in vitro. For this purpose, a novel biofilm model for high-throughput screening of antimicrobial approaches was established comprising A. naeslundii, A. odontolyticus, and S. mutans. A. naeslundii is considered to be an essential early colonizer in dental plaque [Dige et al., 2009] , while A. odontolyticus is suggested to be a key organism mediating adhesion and co-aggregation in supragingival plaque [Tang et al., 2003 ] and is associated with high caries incidence in children [ElSalhy et al., 2016] . S. mutans is well known to play a major role in the pathogenesis of dental caries, mostly due to its ability to produce an insoluble polymeric matrix and due to its acidogenic and aciduric properties [Klein et al., 2015] .
The culture conditions for this biofilm model have been modified from the Zurich biofilm model of supragingival plaque originally described by Guggenheim et al. [2001] : instead of pasteurization of human saliva, filter sterilization was employed because the latter is deemed to be preferable in terms of protein integrity [Ruhl et al., 2011] . Furthermore, concentrations of carbohydrates in mFUM were changed from 0.15% glucose to 0.15% sucrose and 0.15% glucose each, since S. mutans requires sucrose for glucosyltransferase-mediated synthesis of exopolysaccharides [Kreth et al., 2008; Koo et al., 2010] , while Actinomyces spp. preferentially utilize glucose for their metabolism via the Embden-Meyerhof-Parnas pathway [Takahashi and Yamada, 1999] . Proportions of mFUM, saliva, and FBS in the BCM were adjusted to 50, 40, and 10%, respectively, for increasing biofilm density and sturdiness [Ammann et al., 2012] . In contrast to the Zurich biofilm model, biofilms were cultured in 96-well plates rather than on hydroxyapatite discs placed in 24-well plates for ensuring optimal experimental conditions for antimicrobial evaluation of light-based approaches like aPDT. Otherwise, biofilms growing on both sides of the hydroxyapatite discs may have impeded standardized irradiation procedures. Biofilm culture was started with A. naeslundii and A. odontolyticus, while S. mutans was added after 24 h of culture for preventing outgrowth of this species with respect to the slower cell division of Actinomyces spp. relative to streptococci [Dige et al., 2009] . Accordingly, it was recently shown that, when Streptococcus oralis is absent, S. mutans dominates the Zurich biofilm at the expense of Actinomyces oris [Thurnheer and Belibasakis, 2018] . Furthermore, S. mutans colonizes in vitro much less efficiently on streptococcal biofilms than on A. naeslundii biofilms [Wang et al., 2011] . As compared to the Zurich biofilm model of supragingival plaque and its various modifications comprising up to 11 bacterial or fungal species [Guggenheim et al., 2001; Shapiro et al., 2002; Ammann et al., 2012; Belibasakis and Thurnheer, 2014] , this biofilm model is less complex in terms of species diversity but, on the other hand, allows easy and high-throughput screening while still being robust to antimicrobial challenge. Treatment with CHX 2.0% for 20 min served as a positive control leading to total eradication of biofilm bacteria below detection limit. In contrast, treatment with CHX 0.2% resulted in a reduction of ≈4 log 10 steps, while shorter treatment periods exhibited substantially lower inactivation rates (data not shown). This is in line with the literature, where Wilson [1996] reported no antimicrobial effect of CHX 0.2% after treating 72-h old S. mutans biofilms for 5 min but eradication by > 6 log 10 below detection limit after treatment for 60 min. Likewise, Voos et al. [2014] found inactivation of ≈1 log 10 after treating biofilms formed in situ with CHX 0.2% for 3 min, while Hoogenkamp et al. [2009] showed ≈2 log 10 inactivation of S. mutans biofilms after treatment for 5 min. In general, there is a strong and crucial correlation between treatment period and antimicrobial efficacy, especially when it comes to biofilms [Mah and O'Toole, 2001; Stewart and Costerton, 2001] . Diffusion of given antimicrobials into deeper layers of the biofilm may be hampered or slowed by interaction of these positively charged molecules with the negatively charged residues of the biofilm's extracellular polymeric substance [Thurnheer et al., 2003; Tseng et al., 2013] . Therefore, shorter treatment periods may just lead to killing of bacteria in the superficial layers of the biofilm, as it has been shown in the classic study by Zaura-Arite et al. [2001] .
Treatment with aPDT led to less pronounced inactivation rates as compared to CHX. S. mutans was inactivated by 2.8 log 10 , while A. naeslundii and A. odontolyticus exhibited killing rates of 1.2 or 1.3 log 10 only. It is noteworthy to say that despite an identical total treatment period of 20 min (10 min of incubation in the dark followed by 10 min of irradiation), the period of antimicrobial activity of aPDT is limited to the time when the light is switched on. Interestingly, although aPDT is known to be an unselective antimicrobial approach [Wainwright et al., 2017] , S. mutans exhibited noticeably higher susceptibility to phenalen-1-one-mediated aPDT as compared to both A. naeslundii and A. odontolyticus. The influence of subsequent addition of S. mutans, potentially leading to only superficial colonization of this species within the biofilm, can be ruled out because, in this instance, S. mutans would have been inactivated more severely than both Actinomyces spp. in the CHX groups, too. The higher susceptibility of S. mutans to aPDT was further substantiated by investigating antimicrobial efficacy in monospecies biofilms of all 3 species. Likewise, aPDT showed higher inactivation efficacy in S. mutans biofilms (3.0 log 10 ) as compared to A. naeslundii (2.5 log 10 ) and A. odontolyticus (1.1 log 10 ) biofilms. These results are in contrast to a previous study where aPDT with the same PS as used in the present study resulted in a 6.5 log 10 inactivation against A. naeslundii monospecies biofilms [Cieplik et al., 2015] . However, this difference in antimicrobial efficacy may be due to employing a distinct strain (A. naeslundii T14V) and due to the longer incubation period (25 min) [Cieplik et al., 2015] , again elucidating the crucial impact of treatment period.
Actinomyces spp. are generally known for their thick and robust cell walls, which are resistant to salivary lysozyme and other peptidoglycan-hydrolyzing enzymes [Delisle et al., 2006] . Therefore, the higher tolerance to aPDT may be due to an insufficient permeability for PS molecules through the cell membrane, as suggested by Dige et al. [2009] er [Dige et al., 2009] and may even be encapsulated by streptococci, as it has been proposed by Bos et al. [1996] .
To the best of our knowledge, there are no other reports in the literature on the effects of aPDT on polymicrobial biofilms formed in vitro from caries-associated species, such as S. mutans and Actinomyces spp. Therefore, the higher tolerance of Actinomyces spp. to phenalen-1-one-mediated aPDT found here may justify more detailed investigation in future studies, e.g., by using flow cytometry for the investigation of membrane alterations. This phenomenon merits further investigation, as it may be utilized clinically by repeated application of aPDT to induce a shift from highly cariogenic streptococci-dominated to less cariogenic Actinomyces-dominated microbiota in caries-active patients, which may be an interesting approach for biofilm modulation in view of the ecological plaque hypothesis [Marsh et al., 2015] .
However, before any clinical application of phenalen-1-one-mediated aPDT, potential harmful effects on mammalian tissues must be ruled out. As a first step, in a recent study, aPDT with several phenalen-1-one derivatives was investigated for its antimicrobial efficacy in planktonic cultures of dermal pathogens and for its eukaryotic toxicity for keratinocytes as compared to the biocide benzalkonium chloride in order to evaluate a potentially effective concentration range (i.e., ≥5 log 10 steps reduction of CFU while ≥80% survival of keratinocytes) [Muehler et al., 2017] . For the PS used in the present study, no harmful effects were found in the dark. In combination with light, there was a broad effective concentration range, while for benzalkonium chloride no effective concentration range could be found at all [Muehler et al., 2017] . Although these results are encouraging, further biocompatibility studies will be necessary to establish the clinical safety of phenalen-1-one-mediated aPDT.
Conclusion
In this study, a novel caries biofilm model is described comprising A. naeslundii, A. odontolyticus, and S. mutans, which allows easy and high-throughput screening of given compounds or approaches while exhibiting sturdiness towards antimicrobial challenges. While treatment with CHX 0.2% inactivated all species by ≈4 log 10 steps, phenalen-1-one-mediated aPDT led to more pronounced inactivation of S. mutans (2.8 log 10 ) as compared to A. naeslundii (1.2 log 10 ) and A. odontolyticus (1.3 log 10 ), which was similarly found in monospecies biofilms.
